Itovebi

Active Ingredient(s): Inavolisib
FDA Approved: * October 10, 2024
Pharm Company: * GENENTECH INC
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Itovebi 9 mg Oral Tablet, Film Coated
NDC: 50242-079
Labeler:
Genentech, Inc.
Itovebi 3 mg Oral Tablet, Film Coated
NDC: 50242-084
Labeler:
Genentech, Inc.